Tile

STAT Feeds

Exploring health and medicine for a decade.

337 feeds
Loading tags...
Tile
https://www.statnews.com/category/pharma/feed/ RSS

STAT Pharma: The science and business of new drug development

Pharma news: STAT covers pharmaceutical companies through every phase of the drug development lifecycle, from early trials to blockbuster sales, from startups to mergers and acquisitions, from innovative CEOs to Big Pharma lobbyists.
Last seen 5 days ago 6 views
Tile
https://en.ilsole24ore.com/rss/casa--architettura.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago 2 views
Tile
https://en.ilsole24ore.com/rss/casa--protagonisti.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago
Tile
https://statusgator.com/blog/category/integrations/feed/ RSS

Integrations Archives | StatusGator

StatusGator Blog
Last seen 3 weeks ago 17 views
Tile
https://www.nist.gov/news-events/Mathematics%20and%20Statistics/rss.xml RSS

News and Events Feed by Topic

Last seen 1 month ago 7 views
Tile
https://blog.playstation.com/2025/05/05/playstation-store-april-2025s-top-downloads/feed/ RSS

Comments on: PlayStation Store: April 2025’s top downloads

Official PlayStation Blog for news and video updates on PlayStation, PS5, PS4, PS VR, PlayStation Plus and more.
Last seen 2 weeks ago 4 views
Tile
https://en.ilsole24ore.com/rss/casa--finanza-immobiliare.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago 7 views
Tile
https://statusgator.com/blog/category/early-warning-signals/feed/ RSS

Early Warning Signals Archives | StatusGator

StatusGator Blog
Last seen 3 weeks ago 31 views
Tile
https://claudestatus.com/rss.xml RSS

Claude Status

Real-time status updates for Claude services
Last seen 1 month ago 13 views
Tile
https://statusgator.com/blog/feed/ RSS

StatusGator

StatusGator Blog
Last seen 3 weeks ago 14 views
Tile
https://en.ilsole24ore.com/rss/casa--design.xml RSS

Il Sole 24 ORE - Real Estate

Il Sole 24 ORE - Real Estate
Last seen 2 weeks ago 2 views
Tile

View full article
Tile
Select a feed to view its content

Loading feed entries...

STAT+: Kailera’s own ‘triple-G’ drug also looks very powerful

STAT+: Kailera’s own ‘triple-G’ drug also looks very powerful

STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more

STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more

STAT+: Praise for FDA’s acting commissioner

STAT+: Praise for FDA’s acting commissioner

What do early data from Utah’s Doctronic AI pilot show?

What do early data from Utah’s Doctronic AI pilot show?

STAT+: Five biotech news updates to stay on top of today

STAT+: Five biotech news updates to stay on top of today

STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more

STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more

STAT+: Eli Lilly to buy three small vaccine developers

STAT+: Eli Lilly to buy three small vaccine developers

STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA

STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA

Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies

Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies

STAT+: Trump’s pharma deals get tested

STAT+: Trump’s pharma deals get tested

STAT+: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more

STAT+: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more

STAT+: Ahead of ASCO, all eyes on pancreatic cancer

STAT+: Ahead of ASCO, all eyes on pancreatic cancer

STAT+: Trump’s drug-pricing deals set to be tested by new product launches

STAT+: Trump’s drug-pricing deals set to be tested by new product launches

STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study

STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study

STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer

STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer

STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more

STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more

STAT+: Allogene CEO David Chang stepping down

STAT+: Allogene CEO David Chang stepping down

STAT+: Up and down the ladder: The latest comings and goings

STAT+: Up and down the ladder: The latest comings and goings

STAT+: EU and US advisers split over AstraZeneca breast cancer drug

STAT+: EU and US advisers split over AstraZeneca breast cancer drug

STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more

STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more